Eiger BioPharmaceuticals, Inc. (EIGR) SEC filings
EIGR SEC filings moved a median of -6.87% by the close. EIGR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the EIGR overview →
17 measured EIGR SEC filing events.
Where these EIGR SEC filings landedvs 14 measured EIGR SEC filing reactions
| Middle 50% of EIGR SEC filing reactions | -9.47% to +3.58% |
|---|---|
| Median reaction (to close) | -6.87% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 EIGR SEC filing events with a measured close landed between -9.47% and +3.58%; 36% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Eiger BioPharmaceuticals For: May 03 | SEC filing · Form 8-K | — | — | |
| Form 8-K Eiger BioPharmaceuticals For: Apr 26 | SEC filing · Form 8-K | — | — | |
| Form 10-K/A Eiger BioPharmaceuticals For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-K Eiger BioPharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.99% | -5.94% | |
| Form 8-K Eiger BioPharmaceuticals For: Apr 01 | SEC filing · Form 8-K | +0.54% | +22.16% | |
| Form 8-K Eiger BioPharmaceuticals For: Mar 31 | SEC filing · Form 8-K | -10.99% | -7.80% | |
| Form NT 10-K Eiger BioPharmaceuticals For: Dec 31 | SEC filing · Form NT | -10.99% | -7.80% | |
| Form S-8 POS Eiger BioPharmaceuticals | SEC filing · Form S-8 | -10.99% | -7.80% | |
| Form 8-K Eiger BioPharmaceuticals For: Mar 08 | SEC filing · Form 8-K | +0.00% | -10.88% | |
| Form 8-K Eiger BioPharmaceuticals For: Jan 18 | SEC filing · Form 8-K | +0.00% | -1.16% | |
| Form 8-K Eiger BioPharmaceuticals For: Jan 05 | SEC filing · Form 8-K | -7.87% | +6.24% | |
| Form 8-K Eiger BioPharmaceuticals For: Dec 28 | SEC filing · Form 8-K | -3.10% | +3.19% | |
| Form DEF 14A Eiger BioPharmaceuticals For: Dec 28 | SEC filing · Form DEF | -5.64% | -30.16% | |
| Form PRE 14A Eiger BioPharmaceuticals For: Dec 28 | SEC filing · Form PRE | +6.45% | +5.00% | |
| Form 8-K Eiger BioPharmaceuticals For: Nov 10 | SEC filing · Form 8-K | +0.57% | +3.71% | |
| Form 10-Q Eiger BioPharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -3.00% | -10.03% | |
| Form 8-K Eiger BioPharmaceuticals For: Nov 09 | SEC filing · Form 8-K | -3.00% | -10.03% |
Keep exploring
More EIGR: earnings → · analyst actions → · EIGR overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DEMANT HLDG U/ADR (WILYY) | 48 | 0.00% | 18% |
| HLS THERAPEUTICS INC (HLTRF) | 47 | 0.00% | 24% |
| OTSUKA HOLDINGS CO ADR (OTSKY) | 45 | -0.06% | 39% |
| Cipher Pharmaceuticals Inc (CPH_TSE) | 43 | -0.35% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.